Johnson & Johnson say they have temporarily suspended their coronavirus vaccine trial after a trial participant contracted an “unexplained illness”
The big pharma company that has been repeatedly fined for having carcinogenic ingredients in its baby powder products, said it had paused the Phase 3 clinical vaccine trial but offered little detail about the setback.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
RT reports: The pharma firm’s 60,000-patient vaccine study was paused due to an adverse reaction in a volunteer, J&J confirmed to Stat News on Monday, citing privacy concerns while declining to outline the patient’s symptoms.
WEF Insider Reveals 'Bug-Eating Agenda' Is About Destroying the Human Soul
Coolio Was About To Take Down Hollywood Pedophile Ring Before He Died
Pope Francis Vows To Usher In ‘One World Religion’
Bill Gates Caught Admitting ‘Climate Change Is WEF Scam’ to Inner Circle
Elites Panic As Queen’s Death Threatens To Expose Pedophile Ring
WEF Anoint Charles ‘The Great Reset King’
WEF To Force Public To Wear ‘Brain Implants’ So the Elite Can Read Their Minds
Woody Harrelson Slams Big Pharma: 'The Last People You Should Trust With Your Health'
NASA Insider Confesses on Deathbed: I Filmed Fake Moon Landing in 1969
“We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” the company said in a statement.
While J&J said it had ordered a study pause, it clarified that the FDA has not yet placed the trial on clinical hold, which would entail a longer delay in the testing process.
J&J’s vaccine candidate is not the only one thought to be linked to adverse effects in trial volunteers, as AstraZeneca’s inoculation has also resulted in unexplained symptoms in two participants, at least one of which developed a “rare neurological condition” following her second dose, prompting the company to pause testing for a safety review. Though the second patient’s symptoms have not been disclosed, an unnamed source familiar with the trial told the New York Times they exhibited the same illness as the first, a condition known as transverse myelitis.